Talphera, Inc. (TLPH) shareholders
Close on Nov 16, 2026Market cap $44.69MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Rosalind Master Fund L.P. Joint filing with Rosalind Advisors, Inc. (9.90%), Salamon Steven A J (9.90%) and 1 more | 13,957,438 | 9.90% | 13G (passive) amendment | Sep 30, 2025 |
| Aharon Gil Joint filing with Rosalind Advisors, Inc. (9.90%), Salamon Steven A J (9.90%) and 1 more | 12,925,597 | 9.90% | 13G (passive) amendment | Mar 31, 2025 |
| Rosalind Advisors, Inc. Joint filing with Salamon Steven A J (9.90%), Aharon Gil (9.90%) and 1 more | 12,913,182 | 9.90% | 13G (passive) amendment | Jun 30, 2026 |
| CorMedix Inc. | 9,090,909 | 19.95% | 13D (active) | Sep 7, 2025 |
| Salamon Steven A J Joint filing with Rosalind Advisors, Inc. (9.90%), Aharon Gil (9.90%) and 1 more | 7,642,515 | 9.90% | 13G (passive) | Mar 31, 2025 |
| AIGH Capital Management LLC Joint filing with Orin Hirschman (9.80%) | 4,661,502 | 9.80% | 13G (passive) amendment | Dec 31, 2025 |
| Orin Hirschman Joint filing with AIGH Capital Management LLC (9.70%) | 4,454,545 | 9.70% | 13G (passive) | Sep 30, 2025 |
| Rock Springs Capital Management LP Joint filing with Rock Springs Capital LLC (7.88%), Mark Bussard (7.88%) and 2 more | 3,589,186 | 7.88% | 13G (passive) | Sep 10, 2025 |
| Lytton Laurence W Joint filing with Lytton-Kambara Foundation (5.90%) | 2,730,718 | 5.90% | 13G (passive) amendment | Dec 31, 2025 |
| Nantahala Capital Management, LLC Joint filing with Wilmot B. Harkey (11.70%), Daniel Mack (11.70%) | 1,992,519 | 11.70% | 13D (active) amendment | Mar 31, 2025 |
| Daniel Mack Joint filing with Nantahala Capital Management, LLC (11.70%), Wilmot B. Harkey (11.70%) | 1,992,519 | 11.70% | 13D (active) amendment | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TLPH | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 6,985,038 | 13.46% | $7.19M | +3,492,519 | 0.12% |
| Rosalind Advisors, Inc. | 5,169,501 | 9.96% | $5.32M | +1,815,585 | 1.98% |
| AIGH Capital Management LLC | 4,601,502 | 8.87% | $4.74M | −60,000 | 0.30% |
| Rock Springs Capital Management LP | 3,589,186 | 6.91% | $3.70M | – | 0.18% |
| Cantor Fitzgerald, L. P. | 1,774,962 | 3.42% | $1.83M | +887,481 | 0.01% |
| Bleichroeder LP | 1,307,787 | 2.52% | $1.35M | – | 0.24% |
| Dauntless Investment Group, LLC | 746,051 | 1.44% | $768.43K | +310,817 | 0.60% |
| Vanguard Capital Management LLC | 701,877 | 1.35% | $722.93K | +260,266 | 0.00% |
| Caption Management, LLC | 514,969 | 0.99% | $530.42K | −46,851 | 0.00% |
| Almitas Capital LLC | 467,152 | 0.90% | $481.17K | – | 0.12% |
| Geode Capital Management, LLC | 429,062 | 0.83% | $442.00K | +9,082 | 0.00% |
| Shay Capital LLC | 405,764 | 0.78% | $417.94K | +155,681 | 0.03% |
| Vanguard Fiduciary Trust Co | 222,372 | 0.43% | $229.04K | +29,967 | 0.00% |
| Gsa Capital Partners Llp | 209,355 | 0.40% | $216.00K | +115,567 | 0.01% |
| Diadema Partners LP | 153,563 | 0.30% | $158.17K | – | 0.02% |
| UBS Group AG | 129,916 | 0.25% | $133.81K | +116,092 | 0.00% |
| Renaissance Technologies LLC | 113,300 | 0.22% | $116.70K | −124,455 | 0.00% |
| Mariner, LLC | 100,000 | 0.19% | $103.00K | – | 0.00% |
| BlackRock, Inc. | 91,548 | 0.18% | $94.29K | – | 0.00% |
| Northern Trust Corp | 88,296 | 0.17% | $90.95K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 49 | 28M | 54.4% | 13 / 14 | 6 / 8 | 7M | 1M |
| Q1 2026 | 45 | 22M | 42.1% | 13 / 12 | 7 / 4 | 3M | 1M |
| Q4 2025 | 38 | 21M | 40.2% | 10 / 11 | 6 / 6 | 4M | 1M |
| Q3 2025 | 34 | 18M | 34.3% | 7 / 11 | 4 / 5 | 13M | 0M |
| Q2 2025 | 32 | 5M | 10.2% | 4 / 4 | 9 / 4 | 0M | 0M |
| Q1 2025 | 32 | 6M | 10.6% | 4 / 9 | 7 / 6 | 2M | 0M |
| Q4 2024 | 35 | 4M | 7.9% | 10 / 4 | 7 / 4 | 0M | 0M |
| Q3 2024 | 29 | 4M | 8.0% | 4 / 4 | 9 / 4 | 0M | 2M |
| Q2 2024 | 30 | 6M | 12.2% | 3 / 5 | 10 / 4 | 2M | 0M |
| Q1 2024 | 31 | 4M | 8.6% | 4 / 11 | 8 / 6 | 1M | 2M |
| Q4 2023 | 33 | 5M | 10.1% | 6 / 10 | 6 / 4 | 2M | 0M |
| Q3 2023 | 31 | 3M | 6.3% | 9 / 8 | 4 / 5 | 2M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
6 funds held TLPH in Q2 2026, 67% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of TLPH | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 440,104 | 0.85% | $453.31K | 0.00% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 261,773 | 0.50% | $269.63K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 208,775 | 0.40% | $170.36K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 63,382 | 0.12% | $51.72K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 52,389 | 0.10% | $42.75K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 16,366 | 0.03% | $13.35K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Vincent J. Angotti | CHIEF EXECUTIVE OFFICER, Director | 790,767 | 1.52% | Apr 3, 2026 |
| Shakil Aslam | Chief Medical Officer | 76,542 | 0.15% | May 21, 2026 |
| Badri N. Dasu | Chief Engineering Officer | 71,440 | 0.14% | Apr 3, 2026 |
| Raffi Asadorian | Chief Financial Officer | 85,879 | 0.17% | Apr 3, 2026 |
| Jill Marie Broadfoot | Director | 13,647 | 0.03% | Jun 24, 2026 |
| Joseph Todisco | Director | 11,497 | 0.02% | Jun 24, 2026 |
| Marina Bozilenko | Director | 14,147 | 0.03% | Jun 24, 2026 |
| Abhinav Jain | Director | 12,412 | 0.02% | Jun 24, 2026 |
| Adrian Adams | Director | 22,709 | 0.04% | Jun 24, 2026 |
| Mark A. Wan | Director | 140,112 | 0.27% | Jun 24, 2026 |
| Stephen J. Hoffman | Director | 2,885,892 | 5.56% | Jun 24, 2026 |
| Daniel Mack | 10% owner | 1,992,519 | 3.84% | Mar 17, 2026 |
| Wilmot B. Harkey | 10% owner | – | – | Mar 17, 2026 |
| Nantahala Capital Management, LLC | 10% owner | – | – | Mar 17, 2026 |
| Inc. CorMedix | 10% owner | 9,090,909 | 17.51% | Sep 12, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Abhinav Jain Director | Jun 22, 2026 | Award | +5,100 | – | – | 12,412 |
| Adrian Adams Director | Jun 22, 2026 | Award | +5,100 | – | – | 22,709 |
| Mark A. Wan Director | Jun 22, 2026 | Award | +5,100 | – | – | 13,959 |
| Stephen J. Hoffman Director | Jun 22, 2026 | Award | +5,100 | – | – | 13,959 |
| Marina Bozilenko Director | Jun 22, 2026 | Award | +5,100 | – | – | 14,147 |
| Jill Marie Broadfoot Director | Jun 22, 2026 | Award | +5,100 | – | – | 13,647 |
| Joseph Todisco Director | Jun 22, 2026 | Award | +5,100 | – | – | 11,497 |
| Shakil Aslam Chief Medical Officer | May 20, 2026 | Tax withholding | −4,518 | $0.82 | $3.70K | 76,542 |
| Raffi Asadorian Chief Financial Officer | Apr 2, 2026 | Tax withholding | −2,444 | $0.72 | $1.76K | 85,879 |
| Shakil Aslam Chief Medical Officer | Apr 2, 2026 | Tax withholding | −2,118 | $0.72 | $1.52K | 81,060 |
| Badri N. Dasu Chief Engineering Officer | Apr 2, 2026 | Tax withholding | −2,444 | $0.72 | $1.76K | 71,440 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Apr 2, 2026 | Tax withholding | −9,938 | $0.72 | $7.16K | 790,767 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Mar 13, 2026 | Buy | +213,310 | $0.59 | $125.85K | 800,705 |
| Badri N. Dasu Chief Engineering Officer | Feb 14, 2026 | Tax withholding | −2,346 | $0.79 | $1.85K | 73,884 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Feb 14, 2026 | Tax withholding | −9,559 | $0.79 | $7.55K | 577,395 |
| Raffi Asadorian Chief Financial Officer | Feb 14, 2026 | Tax withholding | −2,933 | $0.79 | $2.32K | 88,323 |
| Shakil Aslam Chief Medical Officer | Feb 12, 2026 | Buy | +35,000 | $0.81 | $28.35K | 83,178 |
| Badri N. Dasu Chief Engineering Officer | Feb 12, 2026 | Buy | +35,000 | $0.81 | $28.35K | 76,230 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Feb 12, 2026 | Buy | +105,364 | $0.81 | $85.34K | 586,954 |
| Raffi Asadorian Chief Financial Officer | Feb 12, 2026 | Buy | +45,000 | $0.81 | $36.45K | 91,256 |
| Badri N. Dasu Chief Engineering Officer | Feb 10, 2026 | Tax withholding | −781 | $0.84 | $656 | 41,230 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Feb 10, 2026 | Tax withholding | −3,179 | $0.84 | $2.67K | 481,590 |
| Raffi Asadorian Chief Financial Officer | Feb 10, 2026 | Tax withholding | −958 | $0.84 | $805 | 46,256 |
| Stephen J. Hoffman Director | Oct 23, 2025 | Award | +4,267 | – | – | 8,859 |
| Marina Bozilenko Director | Oct 23, 2025 | Award | +4,267 | – | – | 9,047 |
| Abhinav Jain Director | Oct 23, 2025 | Award | +4,267 | – | – | 7,312 |
| Jill Marie Broadfoot Director | Oct 23, 2025 | Award | +4,267 | – | – | 8,547 |
| Adrian Adams Director | Oct 23, 2025 | Award | +4,267 | – | – | 17,609 |
| Mark A. Wan Director | Oct 23, 2025 | Award | +4,267 | – | – | 8,859 |
| Joseph Todisco Director | Oct 15, 2025 | Award | +6,397 | – | – | 6,397 |
| Shakil Aslam Chief Medical Officer | May 20, 2025 | Tax withholding | −4,517 | $0.52 | $2.35K | 48,178 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Apr 2, 2025 | Award | +61,000 | – | – | 474,769 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Apr 2, 2025 | Buy | +213,310 | $0.59 | $125.85K | 403,769 |
| Raffi Asadorian Chief Financial Officer | Apr 2, 2025 | Award | +15,000 | – | – | 47,214 |
| Badri N. Dasu Chief Engineering Officer | Apr 2, 2025 | Award | +15,000 | – | – | 42,011 |
| Shakil Aslam Chief Medical Officer | Apr 2, 2025 | Award | +15,000 | – | – | 52,695 |
| Badri N. Dasu Chief Engineering Officer | Feb 14, 2025 | Tax withholding | −2,644 | $0.67 | $1.77K | 27,011 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Feb 14, 2025 | Tax withholding | −10,575 | $0.67 | $7.09K | 190,459 |
| Raffi Asadorian Chief Financial Officer | Feb 14, 2025 | Tax withholding | −3,245 | $0.67 | $2.17K | 32,214 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Feb 11, 2025 | Tax withholding | −3,517 | $0.62 | $2.18K | 201,034 |
| Badri N. Dasu Chief Engineering Officer | Feb 11, 2025 | Tax withholding | −880 | $0.62 | $546 | 29,655 |
| Raffi Asadorian Chief Financial Officer | Feb 11, 2025 | Tax withholding | −1,060 | $0.62 | $657 | 35,459 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Feb 10, 2025 | Tax withholding | −3,515 | $0.63 | $2.21K | 204,551 |
| Badri N. Dasu Chief Engineering Officer | Feb 10, 2025 | Tax withholding | −879 | $0.63 | $554 | 30,535 |
| Raffi Asadorian Chief Financial Officer | Feb 10, 2025 | Tax withholding | −1,059 | $0.63 | $667 | 36,519 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Dec 5, 2024 | Buy | +5,000 | $0.64 | $3.20K | 208,066 |
| Raffi Asadorian Chief Financial Officer | Dec 2, 2024 | Sale | −155 | $0.77 | $119 | 37,578 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Nov 27, 2024 | Buy | +5,000 | $0.73 | $3.65K | 203,066 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Aug 30, 2024 | Buy | +7,260 | $1.05 | $7.62K | 198,066 |
| Adrian Adams Director | Jun 24, 2024 | Award | +2,174 | – | – | 13,342 |
| Stephen J. Hoffman Director | Jun 24, 2024 | Award | +2,174 | – | – | 4,592 |
| Jill Marie Broadfoot Director | Jun 24, 2024 | Award | +2,174 | – | – | 4,280 |
| Abhinav Jain Director | Jun 24, 2024 | Award | +2,174 | – | – | 3,045 |
| Marina Bozilenko Director | Jun 24, 2024 | Award | +2,174 | – | – | 4,780 |
| Mark A. Wan Director | Jun 24, 2024 | Award | +2,174 | – | – | 4,592 |
| Shakil Aslam Chief Medical Officer | Jun 14, 2024 | Buy | +5,000 | $1.07 | $5.35K | 37,695 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Jun 14, 2024 | Buy | +1,304 | $1.08 | $1.41K | 180,806 |
| Shakil Aslam Chief Medical Officer | Jun 13, 2024 | Buy | +695 | $0.98 | $681 | 32,695 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Jun 13, 2024 | Buy | +4,570 | $0.97 | $4.43K | 179,502 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Jun 12, 2024 | Buy | +4,126 | $0.97 | $4.00K | 174,932 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Talphera's stock actually held short. Settlement fails (shares not delivered on time) peaked at 6,131 shares on Oct 8, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Raffi Asadorian Officer | Dec 2, 2024 | 155 | $107 | Dec 2, 2024 | Open Market Purchase |
| Pamela Palmer, Trustee of the Pamela P Palmer Revocable Trust DTD 10/17/2014 Officer | Aug 25, 2023 | 7,450 | $8.20K | Aug 25, 2023 | RSUs/Options Excercise |
| Pamela P. Palmer Officer, Director | Aug 24, 2023 | 9,514 | $11.18K | Aug 24, 2023 | Restricted Stock Lapse - See Remarks |
See a number that looks wrong?